Slobbe, Paul <br/><br/>
Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts.  [electronic resource] 

 -  Oncotarget  Jun 2017 
 - 38337-38350 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.16321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carbon Radioisotopes--pharmacokinetics<br/>Cell Line, Tumor<br/>Heterografts<br/>Humans<br/>Indoles--pharmacokinetics<br/>Melanoma--diagnostic imaging<br/>Mice<br/>Mice, Nude<br/>Mutation<br/>Patient Selection<br/>Positron-Emission Tomography<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Radioactive Tracers<br/>Radiopharmaceuticals--pharmacokinetics<br/>Sulfonamides--pharmacokinetics<br/>Tissue Distribution<br/>Vemurafenib